∗Department of Surgery, Erasmus MC – University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
†Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
‡Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
§University of Lille, Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France
¶Division of Upper Gastro-Intestinal Surgery, Department of Surgery, Humanitas University, Humanitas Clinical and Research Center-IRCCS, Milan, Italy
||Department of Oncological Surgery, Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy
∗∗Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
††Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
‡‡Department of Surgery, Connolly Hospital, Dublin, Ireland
§§Department of Public Health, Erasmus MC – University Medical Center, Rotterdam, The Netherlands.
[email protected].
Presented at the International Society for Diseases of the Esophagus, 2020, Toronto.
This study was funded by the Dutch Cancer Society and Netherlands Organization for Health Research and Development.
The authors report no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.annalsofsurgery.com).
